Joshua is the founder of the Althea Group and has extensive experience in business building, sales and marketing. He has a range of proven business and strategy skills and previously held a number of senior management roles at national value-based retailer, Strathfield Group. Joshua founded Althea Health and Wellbeing in 2016, coinciding with registration of the ND Amendment Act, an Act to amend the ND Act, legalising medicinal cannabis.

Vaughan is a seasoned company director and finance executive with over 20 years of experience across diverse sectors, including industrials, mining, and emerging industries. He currently holds a number of Board roles including Chairman in the private sector and has a distinguished background in audit and transaction services with PwC, followed by leadership roles in corporate finance with Australian stockbrokers, including Bell Potter Securities and Wilsons Advisory. Over the past two decades, he has successfully spearheaded numerous capital market transactions, such as Initial Public Offerings (IPOs), secondary market capital raisings, mergers and acquisitions, and pre-IPO private capital raisings. Vaughan’s expertise in corporate finance, risk management, and strategic leadership will be instrumental as the Company expands its operations, innovates in product development, and seeks new growth opportunities both domestically and internationally. His pragmatic approach to complex challenges and proactive board presence will ensure the Group remains agile and resilient in an ever-evolving environment.

Alan is the Chief Financial Officer and Company Secretary of Ridley Corporation Limited, an ASX-listed provider of high-performance animal nutrition solutions. Prior to this role, Alan occupied the same position with listed biotechnology companies Avexa Limited and Zenyth Therapeutics Limited, website pioneer Sausage Software Limited, and unlisted public entity HRL Limited, where he later served as a non-executive director and Chair of the Audit Committee. Alan started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors.

Penny Dobson, is an experienced global healthcare executive and Non-Executive Director. She has worked in the broad life-sciences space since her training as a pharmacist in New Zealand, including many years in the global pharmaceutical industry. Previously, Penny spent many years with Merck and Company Inc and its subsidiaries MSD and Banyu Pharmaceuticals in Australia, New Zealand, the US and Japan. She was Vice President of MSD in Japan and leader of the integration of the Schering Plough acquisition in Japan. Penny is currently principal at Valida Consulting offering a range of services to companies in the healthcare, Pharma, Biotech, Not for Profits and Device and Diagnostic sector.

Robert was previously the Financial Controller for Village Cinemas who are one of the leading cinema operators in Australia. He was responsible for both the financial and commercial activities of the business and acted as a key advisor. He started his career in private practice, with subsequent roles across a range of industries, including Advertising, Construction and Entertainment. Robert is a Certified Practising Accountant.

David was previously Senior Legal Counsel at CPA Australia, a multi-national accounting and finance body. He was responsible for providing commercially focused legal advice to the business, Executive Management Group and Board. David has experience across a breadth of legal commercial matters in numerous jurisdictions. Prior to CPA Australia, David worked with a U.S. headquartered multi-national software company and as a consultant for a global management and professional services firm.